Literature DB >> 23205183

A linkage and association analysis study in the multidrug resistance gene 1 (mdr1) in renal patients.

Mohammad R Bazrafshani1, Kay V Poulton, Merat Mahmoodi.   

Abstract

Several investigations demonstrated that the polymorphisms of multidrug resistance gene (MDR1) gene contribute to interindividual variability in bioavailability and tissue distribution of its substrates. Genotyping of closely spaced single-nucleotide polymorphism (SNP) markers frequently yields highly correlated data, owing to extensive linkage disequilibrium (LD) between markers. The product of multidrug resistance gene (P-gp) is an important molecule, which regulating the bioavailability of many drugs, including calcineurin inhibitors. It also reported that some MDR1 gene polymorphisms (such as 3435C>T) was associated with significantly reduced intestinal P-gp expression in T/T homozygotes. The aim of this study is to develop genotyping assays for polymorphisms of the MDR1 gene, which are believed to have functional properties and to assess the distribution of variant alleles in renal patients (UK Caucasoid). A total of ten polymorphisms in the MDR-1 gene were selected for analysis. Haplotype assays were performed by using EH programme in 172 individuals. The following possible haplotype was apparent (G-41, C-145, C-129, C+139, C+1236, G+2677, G+2956, C+3435, C+4030 and A+4036). This finding suggests the importance of haplotype assignment for the MDR1 gene.

Entities:  

Keywords:  MDR; gene; haplotype; immunosuppressive; linkage disequilibrium; single-nucleotide polymorphism

Year:  2012        PMID: 23205183      PMCID: PMC3508537     

Source DB:  PubMed          Journal:  Int J Mol Epidemiol Genet        ISSN: 1948-1756


  29 in total

1.  Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations.

Authors:  Kun Tang; Soo-Mun Ngoi; Pai-Chung Gwee; John M Z Chua; Edmund J D Lee; Samuel S Chong; Caroline G L Lee
Journal:  Pharmacogenetics       Date:  2002-08

2.  Association between ABCB1 (MDR1) gene 3435 C>T polymorphism and colchicine unresponsiveness of FMF patients.

Authors:  Filiz Ozen; Coskun Silan; Ahmet Uludag; Ferhan Candan; Fatma Silan; Semra Ozdemir; Sinem Atik; Ozturk Ozdemir
Journal:  Ren Fail       Date:  2011-08-18       Impact factor: 2.606

3.  Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man.

Authors:  Lay Beng Goh; Kevin J Spears; Denggao Yao; Andy Ayrton; Paul Morgan; C Roland Wolf; Thomas Friedberg
Journal:  Biochem Pharmacol       Date:  2002-12-01       Impact factor: 5.858

Review 4.  MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors.

Authors:  B L Lum; M P Gosland
Journal:  Hematol Oncol Clin North Am       Date:  1995-04       Impact factor: 3.722

Review 5.  P-glycoprotein: from genomics to mechanism.

Authors:  Suresh V Ambudkar; Chava Kimchi-Sarfaty; Zuben E Sauna; Michael M Gottesman
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

6.  Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.

Authors:  Deanna L Kroetz; Christiane Pauli-Magnus; Laura M Hodges; Conrad C Huang; Michiko Kawamoto; Susan J Johns; Doug Stryke; Thomas E Ferrin; Joseph DeYoung; Travis Taylor; Elaine J Carlson; Ira Herskowitz; Kathleen M Giacomini; Andrew G Clark
Journal:  Pharmacogenetics       Date:  2003-08

Review 7.  Genetic polymorphisms of the human MDR1 drug transporter.

Authors:  Matthias Schwab; Michel Eichelbaum; Martin F Fromm
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

Review 8.  Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.

Authors:  Catia Marzolini; Erik Paus; Thierry Buclin; Richard B Kim
Journal:  Clin Pharmacol Ther       Date:  2004-01       Impact factor: 6.875

9.  P-glycoprotein induction in rat liver epithelial cells in response to acute 3-methylcholanthrene treatment.

Authors:  O Fardel; V Lecureur; A Corlu; A Guillouzo
Journal:  Biochem Pharmacol       Date:  1996-06-14       Impact factor: 5.858

10.  Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan.

Authors:  Kimie Sai; Nahoko Kaniwa; Masaya Itoda; Yoshiro Saito; Ryuichi Hasegawa; Kazuo Komamura; Kazuyuki Ueno; Shiro Kamakura; Masafumi Kitakaze; Kuniaki Shirao; Hironobu Minami; Atsushi Ohtsu; Teruhiko Yoshida; Nagahiro Saijo; Yutaka Kitamura; Naoyuki Kamatani; Shogo Ozawa; Jun-Ichi Sawada
Journal:  Pharmacogenetics       Date:  2003-12
View more
  1 in total

1.  Pharmacokinetic Effect of MDR Gene Polymorphism rs2032582 on the Therapeutic Response in Iraqi Patients with Acute Myeloid Leukemia.

Authors:  Rafid A Abdulkareem; Tamadher Abbas Rafaa; Hamsa Ahmed Jasim; Ahmed Abdul Jabbar Suleiman
Journal:  Avicenna J Med Biotechnol       Date:  2020 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.